Home
About
Overview
Sharing Data
ORCID
Help
History (4)
A phase I dose-escalating study of combination pemetrexed-based chemotherapy and concomitant radiotherapy for locally advanced or metastatic non-small cell lung or esophageal cancer.
Chromatic induction: border contrast or adaptation to surrounding light?
Osteonecrosis of the jaw (ONJ) in cancer patients treated with Bisphosphonates: how the knowledge of a phenomenon can change its evolution.
Targeting KRAS in non-small-cell lung cancer: recent progress and new approaches.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Targeting KRAS in non-small-cell lung cancer: recent progress and new approaches.
Targeting KRAS in non-small-cell lung cancer: recent progress and new approaches. Ann Oncol. 2021 09; 32(9):1101-1110.
View in:
PubMed
subject areas
Carcinoma, Non-Small-Cell Lung
Humans
Lung Neoplasms
Mutation
Piperazines
Proto-Oncogene Proteins p21(ras)
Pyridines
Pyrimidines
authors with profiles
Marina Chiara Garassino